Scientist

Yesterday we published in Scientific American’s blog a call to action about the Scientist-sponsored Rare Disease Science Challenge. If you or a...

Scientist’s very own Kevin Lustig is one of the recipients of this year’s 2012 PharmaVOICE 100 award: Scientist is proud to announce that our own...

Today, we look at our second winner of the Bay Area Open Science Challenge and his work. Derek Jacoby is studying gout treatment and effective...

A couple of months ago, Scientist and BioCurious wrapped up it’s first Open Science Challenge. We had some great proposals submitted, but...

Animal testing is critical to advancing science and learning more about disease, but what animals are effective? It’s safe to say that mice, rats...

The 2011-2012 school year is over, so we decided the next infographic should take a look at how the sciences are faring at schools in the United...

We’ve looked at what happens to a drug when a patent expires, but what happens to the patent owner? As patents have expired and many blockbuster...

As pharmaceutical and biotech research becomes more externalized, it is becoming increasingly important to know who is doing your research. Some...

The price of pharmaceutical drugs has been an issue of national debate for decades. As many blockbuster drugs face patent expiration in a few years...

Mankind has historically tried a range of interesting treatments and medicine, whether it was leeches on the neck or a nice bottle of mercury...